Nanocrystalline silver: Completed Phase II enrollment

NCS completed enrollment of 409 patients with mild to moderate eczema in a double-blind, placebo-controlled, U.S. and Canadian Phase II trial. Patients will be given either 1% or 2% concentrations of ...